GENEVA, July 4 (Reuters) – The World Health Organization (WHO) said on Saturday it would suspend its trials of the antimalarial drug hydroxychloroquine and the combined HIV drug lopinavir / ritonavir in hospitalized patients with COVID-19 after that failed to reduce mortality. “These interim trial results show that hydroxychloroquine and …
Read More »WHO stops hydroxychloroquine, anti-HIV drugs in COVID trials after failing to reduce death
